Skip to main content

Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up

Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, Villemagne VL (2016).

Stay up to date with the latest news from the AIBL study.

In the spirit of reconciliation, AIBL acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea, and community. We pay our deepest respects to their Elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

Sitemap|Copyright © 2024 AIBL | Website by Ethical Design Co.